1. Efficacy and Safety of Abelmoschus manihot for Primary Glomerular Disease: A Prospective, Multicenter Randomized Controlled Clinical Trial 
Li Zhang, MD, PhD, Ping Li, MD, Chang-ying Xing, MD, PhD, Jiu-yang Zhao, MD, Ya-ni He, MD, PhD, Jian-qin Wang, MD, PhD, Xiong- fei Wu, MD, PhD, Zhang-suo Liu, MD, Ai-ping Zhang, MD, Hong-li Lin, MD, PhD, Xiao-qiang Ding, MD, PhD, Ai-ping Yin, MD, PhD, Fa- huan Yuan, MD, Ping Fu, MD, PhD, Li Hao, MD, Li-ning Miao, MD, PhD, Ru-juan Xie, MD, PhD, Rong Wang, MD, PhD, Chun-hua Zhou, MD, PhD, Guang-ju Guan, MD, Zhao Hu, MD, PhD, Shan Lin, MD, Ming Chang, MD, Miao Zhang, MD, PhD, Li-qun He, MD, PhD, Chang-lin Mei, MD, PhD, Li Wang, MD, PhD, Xiangmei Chen, MD, PhD 
American Journal of Kidney Diseases 
Volume 64, Issue 1, Pages (July 2014)
DOI: /j.ajkd
Copyright © 2014 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1 Randomization and flow of patients.
American Journal of Kidney Diseases  , 57-65DOI: ( /j.ajkd )
Copyright © 2014 National Kidney Foundation, Inc. Terms and Conditions